{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:35:51Z","timestamp":1769150151678,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>EQ-5D is generic measure of health-related quality of life. Studies using EQ-5D generate ordinal data that are interpreted as categories ordered by severity. New analytic approaches taking into account the ordinal nature of the health dimension severity and leading to a better interpretation of EQ-5D data are needed to better elucidate differences in health-related quality of life. We propose utilizing the Improved RIDIT statistical method to analyze EQ-5D outcomes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>556 Moroccan participants aged over 18\u2009years representing four chronic diseases: back pain (<jats:italic>n<\/jats:italic>\u2009=\u2009158), renal insufficiency (<jats:italic>n<\/jats:italic>\u2009=\u200956), diabetes (<jats:italic>n<\/jats:italic>\u2009=\u200982) or hypertension (<jats:italic>n<\/jats:italic>\u2009=\u200980) and healthy subjects (<jats:italic>n<\/jats:italic>\u2009=\u2009180). All participants received the two EQ-5D versions. Two other published data sets were included. The first was extracted from a diabetic Spain study and the second was extracted from a clinical trial study. The Improved RIDIT analyses were carried out using an R statistic program we developed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Applying the Improved RIDIT on the EQ-5D data allowed estimating for the first time the ordinal odds, the Absolute Risk Reduction (ARR) or the Absolute Risk Increase (ARI) and the Number Needed to Treat. The ARI values estimated for Moroccan patients showed that (i) hypertension increased anxiety\/depression by 66% and reduced mobility by 65%; (ii) back pain increased pain\/discomfort by 69%; (iii) renal insufficiency impacts mobility (ARI\u2009=\u200957%, odds<jats:sub>ordinal<\/jats:sub>\u2009=\u20099.95) and usual activities (ARI\u2009=\u200944%, odds<jats:sub>ordinal<\/jats:sub>\u2009=\u20096.41) and (iv) diabetes acts only on anxiety\/depression (ARI\u2009=\u200950%, odds<jats:sub>ordinal<\/jats:sub>\u2009=\u20094.8). Also, we demonstrated that the approach works well in clinical trials.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Improved RIDIT provides more intuitive and informative interpretation of the EQ-5D data by (1) taking into account the level severity; estimating (2) the odds ordinal, (3) the ARR\/ARI and the NNT; (4) analyzing the five dimensions of the EQ-5D separately, which gives clinical teams more precision in understanding the treatment\/pathology impacts on the health status and completes the EQ-5D data analysis based on score utilities.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12955-020-01313-3","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T11:02:50Z","timestamp":1583838170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improved RIDIT statistic approach provides more intuitive and informative interpretation of EQ-5D data"],"prefix":"10.1186","volume":"18","author":[{"given":"Abdelghafour","family":"Marfak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtissam","family":"Youlyouz-Marfak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youness","family":"El Achhab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmadani","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakib","family":"Nejjari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderraouf","family":"Hilali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Turman Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"issue":"1","key":"1313_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12955-016-0530-7","volume":"14","author":"N Safita","year":"2016","unstructured":"Safita N, Islam SM, Chow CK, Niessen L, Lechner A, Holle R, Laxy M. The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls. Health Qual Life Outcomes. 2016;14(1):129\u201337.","journal-title":"Health Qual Life Outcomes"},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12955-015-0356-8","volume":"13","author":"Y Feng","year":"2015","unstructured":"Feng Y, Devlin N, Herdman M. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes. 2015;13:171\u201386.","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"1313_CR3","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s11136-012-0318-0","volume":"22","author":"L Scalone","year":"2013","unstructured":"Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, et al. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res. 2013;22(7):1707\u201316.","journal-title":"Qual Life Res"},{"issue":"1","key":"1313_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1477-7525-10-132","volume":"10","author":"B Tran","year":"2012","unstructured":"Tran B, Ohinmaa A, Nguyen L. Quality of life profile and psychometric properties of the EQ-5D-5 L in HIV\/AIDS patients. Health Qual Life Outcomes. 2012;10(1):132\u201340.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"1313_CR5","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s11136-014-0670-3","volume":"23","author":"YX Jia","year":"2014","unstructured":"Jia YX, Cui FQ, Li L, Zhang DL, Zhang GM, Wang FZ, et al. Comparison between the EQ-5D-5 L and the EQ-5D-3 L in patients with hepatitis B. Qual Life Res. 2014;23(8):2355\u201363.","journal-title":"Qual Life Res"},{"issue":"2","key":"1313_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1524-4733.2009.00610.x","volume":"13","author":"Y Peeters","year":"2010","unstructured":"Peeters Y, Stiggelbout AM. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities. Value Health. 2010;13(2):306\u20139.","journal-title":"Value Health"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/01.mlr.0000172050.67085.4f","volume":"43","author":"PW Sullivan","year":"2005","unstructured":"Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference based scores for chronic conditions in the United States. Med Care. 2005;43:736\u201349.","journal-title":"Med Care"},{"key":"1313_CR8","first-page":"517","volume":"113","author":"N Devlin","year":"2000","unstructured":"Devlin N, Hansen P, Herbison P. Variations in self-reported health status: results from a New Zealand survey. N Z Med J. 2000;113:517\u201320.","journal-title":"N Z Med J"},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11136-013-0498-2","volume":"23","author":"A Hinz","year":"2014","unstructured":"Hinz A, Kohlmann T, St\u00f6bel-Richter Y, Zenger M, Br\u00e4hler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23:443\u20137.","journal-title":"Qual Life Res"},{"issue":"2","key":"1313_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11136-013-0488-4","volume":"23","author":"LN Ferreira","year":"2014","unstructured":"Ferreira LN, Ferreira PL, Pereira LN, Oppe M. EQ-5D Portuguese population norms. Qual Life Res. 2014;23(2):425\u201330.","journal-title":"Qual Life Res"},{"issue":"9","key":"1313_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jclinepi.2014.04.005","volume":"67","author":"A Devine","year":"2014","unstructured":"Devine A, Taylor SJ, Spencer A, Diaz-Ordaz K, Eldridge S, Underwood M. The agreement between proxy and self-completed EQ-5D for care home residents was better for index scores than individual domains. J Clin Epidemiol. 2014;67(9):1035\u201343.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"1313_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jclinepi.2009.11.021","volume":"63","author":"H Liu","year":"2010","unstructured":"Liu H, Cella D, Gershon R, Shen J, Morales LS, Riley W, et al. Representativeness of the patient-reported outcomes measurement information system internet panel. J Clin Epidemiol. 2010;63(11):1169\u201378.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"1313_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s11136-016-1460-x","volume":"26","author":"Z Hakimi","year":"2017","unstructured":"Hakimi Z, Herdman M, Pavesi M, Devlin N, Nazir J, Hoyle C, Odeyemi IA. Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Qual Life Res. 2017;26(5):1187\u201395.","journal-title":"Qual Life Res"},{"issue":"1","key":"1313_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12955-017-0704-y","volume":"15","author":"N Devlin","year":"2017","unstructured":"Devlin N, Herdman M, Pavesi M, Phung D, Naidoo S, Beer TM, Tombal B, et al. Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial. Health Qual Life Outcomes. 2017;15(1):130.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1313_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s11136-017-1753-8","volume":"27","author":"C Otto","year":"2018","unstructured":"Otto C, Barthel D, Klasen F, Nolte S, Rose M, Meyrose AK, et al. Predictors of self-reported health-related quality of life according to the EQ-5D-Y in chronically ill children and adolescents with asthma, diabetes, and juvenile arthritis: longitudinal results. Qual Life Res. 2018;27(4):879\u201390.","journal-title":"Qual Life Res"},{"issue":"1","key":"1313_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12955-017-0590-3","volume":"15","author":"D Scott","year":"2017","unstructured":"Scott D, Ferguson GD, Jelsma J. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study. Health Qual Life Outcomes. 2017;15(1):12.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1313_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5271\/sjweh.446","volume":"25","author":"J Kildes\u00f8","year":"1999","unstructured":"Kildes\u00f8 J, Wyon D, Skov T, Schneider T. Visual analogue scales for detecting changes in symptoms of the sick building syndrome in an intervention study. Scand J Work Environ Health. 1999;25(4):361\u20137.","journal-title":"Scand J Work Environ Health"},{"issue":"4","key":"1313_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nur.4770130405","volume":"13","author":"ME Wewers","year":"1990","unstructured":"Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13(4):227\u201336.","journal-title":"Res Nurs Health"},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2307\/2527727","volume":"14","author":"DJ Bross","year":"1958","unstructured":"Bross DJ. How to use Ridit analysis. Biometrics. 1958;14:18\u201338.","journal-title":"Biometrics"},{"key":"1313_CR20","unstructured":"Flora JD. A Note on Ridit Analysis. Technical report No. UM-HSRI-SA-74-10. 1974; Highway Safety Research Institute, University of Michigan. 1974."},{"issue":"1","key":"1313_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/aoms\/1177730491","volume":"18","author":"HB Mann","year":"1947","unstructured":"Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat. 1947;18(1):50\u201360.","journal-title":"Ann Math Stat"},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1214\/aos\/1176342560","volume":"1","author":"WJ Conover","year":"1973","unstructured":"Conover WJ. Rank tests for one sample, two samples and K samples without the assumptions of a continuous distribution function. Ann Stat. 1973;1:1105\u201325.","journal-title":"Ann Stat"},{"issue":"4","key":"1313_CR23","first-page":"1595","volume":"32","author":"DC Mateo","year":"2015","unstructured":"Mateo DC, Gordillo MG, Olivares PR, Adsuar JC. Normative values of EQ-5D-5L for diabetes patients from Spain. Nutr Hosp. 2015;32(4):1595\u2013602.","journal-title":"Nutr Hosp"},{"issue":"2","key":"1313_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1524-4733.2007.00230.x","volume":"11","author":"MF Janssen","year":"2008","unstructured":"Janssen MF, Birnie E, Haagsma JA, Bonsel GJ. Comparing the standard EQ-5D three-level system with a five- level version. Value Health. 2008;11(2):275\u201384.","journal-title":"Value Health"},{"issue":"2","key":"1313_CR25","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65\u201370.","journal-title":"Scand J Stat"},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1136\/jech.55.1.7","volume":"55","author":"L Shepstone","year":"2001","unstructured":"Shepstone L. Re-conceptualising and generalising the absolute risk difference: a unification of effect sizes, odds ratios and number-needed-to-treat. J Epidemiol Community Health. 2001;55:A7.","journal-title":"J Epidemiol Community Health"},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-7525-2-26","volume":"2","author":"SJ Walters","year":"2004","unstructured":"Walters SJ. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36. Health Qual Life Outcomes. 2004;2:26.","journal-title":"Health Qual Life Outcomes"},{"issue":"19","key":"1313_CR28","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2146\/ajhp040558","volume":"62","author":"L Wen","year":"2005","unstructured":"Wen L, Badgett R, Cornell J. Number needed to treat: a descriptor for weighing therapeutic options. Am J Health Syst Pharm. 2005;62(19):2031\u20136.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"1313_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2307\/2530495","volume":"36","author":"A Agresti","year":"1980","unstructured":"Agresti A. Generalized odds ratios for ordinal data. Biometrics. 1980;36(1):59\u201367.","journal-title":"Biometrics"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-020-01313-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T23:16:31Z","timestamp":1629501391000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-020-01313-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1186\/s12955-020-01313-3","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval provided from the ethics committee of the Hassan 1st University (Settat, Morocco).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}